211 related articles for article (PubMed ID: 15868919)
1. Neuroendocrine differentiation in primary Merkel cell carcinoma--possible prognostic significance.
Koljonen V; Haglund C; Tukiainen E; Böhling T
Anticancer Res; 2005; 25(2A):853-8. PubMed ID: 15868919
[TBL] [Abstract][Full Text] [Related]
2. Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft.
Krasagakis K; Almond-Roesler B; Geilen C; Fimmel S; Krengel S; Chatzaki E; Gravanis A; Orfanos CE
J Cell Physiol; 2001 Jun; 187(3):386-91. PubMed ID: 11319762
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
[TBL] [Abstract][Full Text] [Related]
4. p63 expression as a new prognostic marker in Merkel cell carcinoma.
Asioli S; Righi A; Volante M; Eusebi V; Bussolati G
Cancer; 2007 Aug; 110(3):640-7. PubMed ID: 17599745
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinoma.
Fernández-Figueras MT; Puig L; Musulen E; Gilaberte M; Ferrándiz C; Lerma E; Ariza A
Histopathology; 2005 Jun; 46(6):614-21. PubMed ID: 15910592
[TBL] [Abstract][Full Text] [Related]
6. Merkel cell carcinoma with eccrine differentiation: a clinicopathologic study of 7 cases.
Saeb-Lima M; Montante-Montes de Oca D; Albores-Saavedra J
Ann Diagn Pathol; 2008 Dec; 12(6):410-4. PubMed ID: 18995205
[TBL] [Abstract][Full Text] [Related]
7. The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study.
van Krimpen C; Elferink A; Broodman CA; Hop WC; Pronk A; Menke M
Breast; 2004 Aug; 13(4):329-33. PubMed ID: 15325669
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma.
Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer.
Cho YB; Yang SS; Lee WY; Song SY; Kim SH; Shin HJ; Yun SH; Chun HK
Int J Surg Pathol; 2010 Jun; 18(3):201-6. PubMed ID: 19372085
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous neuroendocrine cell carcinoma (Merkel cell carcinoma) with prominent microcystic features, mimicking eccrine carcinoma.
Li N; Wolgamot G; Argenyi Z
J Cutan Pathol; 2007 May; 34(5):410-4. PubMed ID: 17448197
[TBL] [Abstract][Full Text] [Related]
11. Expression of TdT in Merkel cell carcinoma and small cell lung carcinoma.
Sidiropoulos M; Hanna W; Raphael SJ; Ghorab Z
Am J Clin Pathol; 2011 Jun; 135(6):831-8. PubMed ID: 21571955
[TBL] [Abstract][Full Text] [Related]
12. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
[TBL] [Abstract][Full Text] [Related]
13. A case series and immunophenotypic analysis of CK20-/CK7+ primary neuroendocrine carcinoma of the skin.
Calder KB; Coplowitz S; Schlauder S; Morgan MB
J Cutan Pathol; 2007 Dec; 34(12):918-23. PubMed ID: 18001414
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell carcinoma: a clinicopathological study of 11 cases.
Acebo E; Vidaurrazaga N; Varas C; Burgos-Bretones JJ; Díaz-Pérez JL
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):546-51. PubMed ID: 16164706
[TBL] [Abstract][Full Text] [Related]
15. [Immunophenotypic characterization of cutaneous neuroendocrine carcinoma derived from Merkel cells].
Pozharisskiĭ KM; Ivanova AIu; Leenman EE; Abroian NA
Arkh Patol; 1996; 58(5):13-8. PubMed ID: 9005817
[TBL] [Abstract][Full Text] [Related]
16. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance].
Ouyang N; Chen G; Ding J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946
[TBL] [Abstract][Full Text] [Related]
17. Primary neuroendocrine carcinoma of the vagina with Merkel cell carcinoma phenotype.
Coleman NM; Smith-Zagone MJ; Tanyi J; Anderson ML; Coleman RL; Dyson SW; Reed JA
Am J Surg Pathol; 2006 Mar; 30(3):405-10. PubMed ID: 16538063
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation in follicle-cell thyroid carcinoma: correlation to prognostic factors in papillary carcinoma.
Tseleni-Balafouta S; Kavantzas N; Alevizaki M; Paraskevakou H; Davaris P
J Exp Clin Cancer Res; 1998 Dec; 17(4):533-7. PubMed ID: 10089080
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer.
Quek ML; Daneshmand S; Rodrigo S; Cai J; Dorff TB; Groshen S; Skinner DG; Lieskovsky G; Pinski J
Urology; 2006 Jun; 67(6):1247-52. PubMed ID: 16697447
[TBL] [Abstract][Full Text] [Related]
20. Divergent neuroendocrine differentiation in prostatic carcinoma.
di Sant' Agnese PA
Semin Diagn Pathol; 2000 May; 17(2):149-61. PubMed ID: 10839615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
